ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Tango Therapeutics Inc

Tango Therapeutics Inc (TNGX)

3.715
-0.365
( -8.95% )
更新日時: 03:22:06

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
3.715
買値
3.71
売値
3.72
出来高
1,998,484
3.58 日の範囲 4.22
2.70 52 週間の範囲 13.005
時価総額
前日終値
4.08
始値
4.07
最終取引時間
03:24:00
財務取引量
US$ 7,863,295
VWAP
3.9346
平均取引量 (3 か月)
1,898,956
発行済株式数
107,417,818
配当利回り
-
PER
-3.85
1 株当たり利益 (EPS)
-0.95
歳入
36.53M
純利益
-101.74M

Tango Therapeutics Inc について

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Tango Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker TNGX. The last closing price for Tango Therapeutics was US$4.08. Over the last year, Tango Therapeutics shares have traded in a share price range of US$ 2.70 to US$ 13.005.

Tango Therapeutics currently has 107,417,818 shares in issue. The market capitalisation of Tango Therapeutics is US$438.26 million. Tango Therapeutics has a price to earnings ratio (PE ratio) of -3.85.

TNGX 最新ニュース

Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights

– Positive TNG462 clinical activity across multiple tumor types in the phase 1/2 clinical trial, program moving into full development with multiple combination studies – – Clinical collaboration...

Tango Therapeutics Reports Positive TNG462 Clinical Data and Provides Update on PRMT5 Development Program

– TNG462 demonstrated durable clinical activity across multiple tumor types, including non-small cell lung cancer (NSCLC) and pancreatic cancer, in ongoing phase 1/2 clinical trial, moving into...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.0651.780821917813.654.223.530942283.88518512CS
4-2.465-39.88673139166.186.982.734210023.82922998CS
12-7.685-67.412280701811.411.922.718989565.57672376CS
26-3.915-51.31061598957.6312.0152.712715336.66445178CS
52-3.875-51.05401844537.5913.0052.79460837.57983127CS
156-8.195-68.807724601211.9113.032.476745727.40406089CS
260-5.895-61.3423517179.6118.842.476346227.60985813CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
WORXSCWorx Corporation
US$ 2.16
(120.41%)
123.95M
CRNCCerence Inc
US$ 5.57
(97.52%)
50.59M
PROCProcaps Group SA
US$ 0.92
(60.98%)
92.72k
SPAISafe Pro Group Inc
US$ 4.5708
(42.84%)
38.55M
ARQQArqit Quantum Inc
US$ 9.88
(34.60%)
479.65k
SKKSKK Holdings Limited
US$ 1.53
(-66.45%)
14.84M
WCTWellchange Holdings Company Limited
US$ 1.30
(-60.84%)
1.31M
GLXGGalaxy Payroll Group Ltd
US$ 2.0701
(-47.06%)
1.95M
TMTCTMT Acquisition Corporation
US$ 3.455
(-46.35%)
39.98k
PYXSPyxis Oncology Inc
US$ 2.115
(-44.63%)
12.06M
CDTConduit Pharmaceuticals Inc
US$ 0.1151
(24.70%)
544.32M
NVDANVIDIA Corporation
US$ 145.045
(-0.58%)
271.34M
AKTSAkoustis Technologies Inc
US$ 0.102
(17.11%)
194.79M
ELABElevai Labs Inc
US$ 0.0206
(-3.74%)
192.33M
WORXSCWorx Corporation
US$ 2.14
(118.37%)
124.91M

最近閲覧した銘柄

Delayed Upgrade Clock